Invesco’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.89M Buy
310,684
+157,542
+103% +$1.37M ﹤0.01% 2393
2025
Q4
$1.15M Buy
153,142
+26,563
+21% +$269K ﹤0.01% 2852
2025
Q3
$1.1M Sell
126,579
-13,746
-10% -$82.2K ﹤0.01% 2882
2025
Q2
$521K Buy
140,325
+22,557
+19% +$79.3K ﹤0.01% 3139
2025
Q1
$380K Buy
117,768
+89,611
+318% +$422K ﹤0.01% 3265
2024
Q4
$157K Buy
28,157
+732
+3% +$5.74K ﹤0.01% 3556
2024
Q3
$296K Sell
27,425
-27
-0.1% -$448 ﹤0.01% 3419
2024
Q2
$576K Sell
27,452
-217
-0.8% -$5.44K ﹤0.01% 3217
2024
Q1
$882K Buy
27,669
+13,591
+97% +$347K ﹤0.01% 3054
2023
Q4
$285K Sell
14,078
-3,398
-19% -$44.7K ﹤0.01% 3451
2023
Q3
$222K Sell
17,476
-198,100
-92% -$3.31M ﹤0.01% 3552
2023
Q2
$3.9M Buy
+215,576
New +$3.97M ﹤0.01% 2361
2023
Q1
Sell
-196,201
Closed -$4.36M 3912
2022
Q4
$4.36M Buy
196,201
+185,652
+1,760% +$2.87M ﹤0.01% 2320
2022
Q3
$85K Sell
10,549
-104
-1% -$942 ﹤0.01% 3861
2022
Q2
$75K Sell
10,653
-92
-0.9% -$894 ﹤0.01% 3933
2022
Q1
$163K Sell
10,745
-235
-2% -$3.69K ﹤0.01% 3804
2021
Q4
$241K Buy
+10,980
New +$269K ﹤0.01% 3709

Other funds holding FDMT